Australian Prescriber – New Issue

4 Aug, 2014

   
 

The August issue is online now

 

From the Editor

   

The quality use of medicines requires that drugs are used safely and judiciously. Ahamed Zawab and John Carmody discuss how this can be achieved when prescribing sodium valproate, while Rebecca Adams and Robert Bird advise on the quality use of blood products.

Sometimes it is better not to prescribe a drug. This is often the case in childhood coughs, say Danielle Wurzel, Julie Marchant and Anne Chang.

Similar principles apply to the use of nutritional supplements. Anne Schneyder says that the first step in managing elderly people at risk of malnutrition is eating real food.

The quality use of medicines also requires an awareness of drug interactions. Andrew Finch and Peter Pillans explain the role of P-glycoprotein in some interactions.

   

Continuing Professional Development

   

Australian Prescriber provides Continuing Professional Development (CPD) activities for pharmacists. This means that pharmacists can claim CPD points by testing what they learn from reading articles published in Australian Prescriber.

Activities are designed to take about one hour to complete – reading an article and completing an online quiz – and can be included in a pharmacist’s CPD plan for two Group 2 non-accredited CPD credits.

To learn more or to participate in the latest activities, visit www.australianprescriber.com/continuing-professional-development.

   

Volume 37 Number 4 August 2014

   

EDITORIAL

   
   

Cost shifting and the quality use of medicines: Is it time for National Medicines Policy 2.0? 
AJ McLachlan

   
   

ARTICLES

   
   

Drug treatments of childhood coughs 
DF Wurzel, JM Marchant, AB Chang

   
   

Malnutrition and nutritional supplements
A Schneyder

   
   

Safe use of sodium valproate 
A Zawab, J Carmody

   
   

Quality use of blood products 
RLC Adams, R Bird

   
   

P-glycoprotein and its role in drug-drug interactions 
A Finch, P Pillans

   
   

LETTERS TO THE EDITOR

   
   

FEATURES

   
   

Medicines Safety Update

   
    Book review

Anterior eye disease and therapeutics A–Z

   
   

NEW DRUGS

   
   

Afatinib for non small cell lung carcinoma

   
   

Macitentan for pulmonary arterial hypertension

   
   

Riociguat for pulmonary hypertension

   
 

Happy reading! from Australian Prescriber

 
    To keep updated on editorials, articles and new drug summaries ahead of print, follow Australian Prescriber on Twitter    
   

Change your email address or unsubscribe

Request a paper copy

   
    nps    
header